Natus Medical Incorporated (Nasdaq:BABY) announced financial results for the fourth quarter and full year ended December 31, 2009.

For the fourth quarter ended December 31, 2009, Natus reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008.

For the year ended December 31, 2009, Natus reported revenue of $166.5 million, compared to $161.8 million reported in 2008. Net income was $11.1 million, or $0.39 per diluted share for the year ended December 31, 2009, compared to net income of $17.5 million, or $0.66 per diluted share in 2008.

The results for the full year 2009 include $550,000 of direct acquisition costs associated with the Company’s acquisitions of Hawaii Medical and Alpine Biomed in July and September 2009, respectively. Excluding these direct costs, which were reported as a component of general and administrative expense, non-GAAP earnings were $11.5 million, or $0.40 per diluted share.

As of December 31, 2009 the Company had cash, cash equivalents, and short-term investments of $33.5 million, stockholders’ equity of approximately $243 million, and working capital of approximately $76 million.

Related posts

• Analysis of the Proposed Health Care Legislation Finds Financial Aspects May be Difficult to Forecast (0)
• Medical Health Insurance in Florida: Allegiance Financial Notes Many Finding Better Coverage by Leaving Their Employer Plans Behind (0)
• China Pharmaceuticals, Inc. (CFMI) Reports Record Q2 Results: Sales Grow 105% (0)
• Bio-Reference Laboratories, Inc. Announces 25% Revenue Growth, 17% Patient Growth, Record Income (0)
• Synovis Life Technologies Reports 17 Percent Year-Over-Year Revenue Growth for Fiscal 2010 Third Quarter (0)